share_log

Benitec Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Citadel Advisors LLC(6.9%),Citadel Advisors Holdings LP(6.9%),Citadel GP LLC(6.9%),Kenneth Griffin(6.9%),Citadel Securities LLC(0.0%),Citadel Securities Group LP(0.

Benitec Biopharma | SC 13G:超過5%持股股東披露文件-Citadel Advisors LLC(6.9%),Citadel Advisors Holdings LP(6.9%),Citadel GP LLC(6.9%),Kenneth Griffin(6.9%),Citadel Securities LLC(0.0%),Citadel Securities Group L

美股sec公告 ·  2023/08/21 16:07
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息